The characteristics and risk factors of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis

被引:47
|
作者
Tobari, Maki [1 ,2 ]
Hashimoto, Estuko [3 ]
Taniai, Makiko [3 ]
Kodama, Kazuhisa [3 ]
Kogiso, Tomomi [3 ]
Tokushige, Katsutoshi [3 ]
Yamamoto, Masakazu [4 ]
Takayoshi, Nishino [1 ,2 ]
Satoshi, Katagiri [5 ]
Tatsuo, Araida [5 ]
机构
[1] Tokyo Womens Med Univ, Dept Internal Med, Yachiyo Med Ctr, Chiba, Japan
[2] Tokyo Womens Med Univ, Dept Gastroenterol, Yachiyo Med Ctr, Chiba, Japan
[3] Tokyo Womens Med Univ, Dept Surg, Yachiyo Med Ctr, Chiba, Japan
[4] Tokyo Womens Med Univ, Inst Gastroenterol, Dept Internal Med, Tokyo, Japan
[5] Tokyo Womens Med Univ, Inst Gastroenterol, Dept Surg, Tokyo, Japan
关键词
AFLD; alcohol consumption; non-cirrhotic NAFLD; HCC; HCC in non-cirrhosis; NASH; risk factors for HCC; CLINICAL-PRACTICE GUIDELINES; JAPANESE PATIENTS; SCORING SYSTEM; MANAGEMENT; DIAGNOSIS; ALGORITHM; CANCER;
D O I
10.1111/jgh.14867
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aim We evaluated the characteristics of hepatocellular carcinoma (HCC) in patients who had non-alcoholic fatty liver disease (NAFLD) without cirrhosis. Methods We prospectively followed NAFLD patients at our University hospital. NAFLD was diagnosed from detection of steatosis by histology or imaging, no alcohol intake, and exclusion of other liver diseases. Cirrhosis was defined by histological features, imaging data, and symptoms. We compared NAFLD-related HCC with or without cirrhosis and non-cirrhotic NAFLD with or without HCC. Results There were 48 non-cirrhotic HCC patients and 71 cirrhotic HCC patients. Multiple logistic regression analysis revealed that other than liver function factors, male gender (OR: 5.603, 95%CI: 1.577-19.900), light drinker (OR: 2.797, 95%CI: 1.031-7.589), and tumor size (OR: 1.031, 95%CI 1.009-1.055) differ significantly between these two groups. The recurrence rate was significantly lower in the non-cirrhotic HCC group than the cirrhotic HCC group, with risk factors being des-gamma-carboxy prothrombin and the number of HCCs. The non-cirrhotic HCC group showed significantly better survival because of absence of non-cancerous liver failure. Comparison between non-cirrhotic NAFLD patients with or without HCC (n = 612) revealed the following risk factors for HCC: male gender (OR: 7.774, 95%CI: 2.176-27.775), light drinker (OR: 4.893, 95%CI: 1.923-12.449), and high FIB4 index (OR 2.634, 95%CI: 1.787-3.884). Conclusion In patients with non-cirrhotic NAFLD, important risk factors for HCC were male gender, alcohol consumption, and the FIB4 index. HCC recurrence and survival were only influenced by the tumor stage. We should be aware of alcohol consumption as a modifiable risk factor for HCC.
引用
收藏
页码:862 / 869
页数:8
相关论文
共 50 条
  • [1] CLINICAL AND TUMOR CHARACTERISTICS OF NONALCOHOLIC FATTY LIVER DISEASE ASSOCIATED HEPATOCELLULAR CARCINOMA IN PATIENTS WITH AND WITHOUT CIRRHOSIS
    Benhammou, Jihane N.
    Aby, Elizabeth S.
    Lin, Jonathan
    Markovic, Daniela
    Tong, Myron J.
    [J]. HEPATOLOGY, 2020, 72 : 631A - 632A
  • [2] Diabetes and Risk of Hepatocellular Carcinoma in Cirrhosis Patients with Nonalcoholic Fatty Liver Disease
    Teng, Pai-Chi
    Huang, Daniel Q.
    Lin, Ting-Yi
    Noureddin, Mazen
    Yang, Ju Dong
    [J]. GUT AND LIVER, 2023, 17 (01) : 24 - 33
  • [3] THE CHARACTERISTICS AND RISK FACTORS OF HEPATOCELLULAR CARCINOMA IN NON-ALCOHOLIC FATTY LIVER DISEASE WITHOUT CIRRHOSIS.
    Tobari, Maki
    Hashimoto, Etsuko
    Taniai, Makiko
    Sagawa, Takaomi
    Kodama, Kazuhisa
    Kogiso, Tomomi
    Nishino, Takayoshi
    Tokushige, Katsutoshi
    [J]. HEPATOLOGY, 2019, 70 : 1344A - 1344A
  • [4] Incidence of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis or advanced liver fibrosis
    Behari, Jaideep
    Gougol, Amir
    Wang, Renwei
    Luu, Hung N.
    Paragomi, Pedram
    Yu, Yi-Chuan
    Molinari, Michele
    Chopra, Kapil
    Malik, Shahid M.
    Geller, David
    Yuan, Jian-Min
    [J]. HEPATOLOGY COMMUNICATIONS, 2023, 7 (07)
  • [5] INCIDENCE AND CLINICAL CHARACTERISTICS OF HEPATOCELLULAR CARCINOMA ASSOCIATED WITH NONALCOHOLIC FATTY LIVER DISEASE WITHOUT CIRRHOSIS OR ADVANCED LIVER FIBROSIS
    Behari, Jaideep
    Wang, Renwei
    Luu, Hung N.
    Paragomi, Pedram
    Yu, Yi-Chuan
    Molinari, Michele
    Chopra, Kapil B.
    Malik, Shahid M.
    Geller, David A.
    Yuan, Jian-Min
    [J]. HEPATOLOGY, 2021, 74 : 90A - 90A
  • [6] Hepatocellular carcinoma in nonalcoholic fatty liver disease with or without cirrhosis: a population-based study
    Kanokwan Pinyopornpanish
    George Khoudari
    Mohannad Abou Saleh
    Chaisiri Angkurawaranon
    Kanokporn Pinyopornpanish
    Emad Mansoor
    Srinivasan Dasarathy
    Arthur McCullough
    [J]. BMC Gastroenterology, 21
  • [7] Hepatocellular carcinoma in nonalcoholic fatty liver disease with or without cirrhosis: a population-based study
    Pinyopornpanish, Kanokwan
    Khoudari, George
    Abou Saleh, Mohannad
    Angkurawaranon, Chaisiri
    Pinyopornpanish, Kanokporn
    Mansoor, Emad
    Dasarathy, Srinivasan
    McCullough, Arthur
    [J]. BMC GASTROENTEROLOGY, 2021, 21 (01)
  • [8] Nonalcoholic fatty liver disease without cirrhosis is an emergent and independent risk factor of hepatocellular carcinoma: A population based study
    Rahman, Rubayat N.
    Ibdah, Jamal A.
    [J]. HEPATOLOGY, 2012, 56 : 241A - 241A
  • [9] Influence of Nonalcoholic Fatty Liver Disease With Increased Liver Enzyme Levels on the Risk of Cirrhosis and Hepatocellular Carcinoma
    Huang, Yu-Han
    Chan, Chi
    Lee, Hye-Won
    Huang, Claire
    Chen, Yen-Ju
    Liu, Po-Chun
    Lu, Sheng-Nan
    Chuang, Wan-Long
    Huang, Jee-Fu
    Yu, Ming-Lung
    Koshiol, Jill
    Lee, Mei-Hsuan
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (04) : 960 - 969
  • [10] Risk factors for hepatocellular carcinoma in cirrhosis due to nonalcoholic fatty liver disease: A multicenter, case-control study
    Kathleen E Corey
    Samer Gawrieh
    Andrew S deLemos
    Hui Zheng
    Andrew E Scanga
    Jennifer W Haglund
    Jorge Sanchez
    Christopher J Danford
    Megan Comerford
    Krista Bossi
    Samina Munir
    Naga Chalasani
    Julia Wattacheril
    [J]. World Journal of Hepatology, 2017, (07) : 385 - 390